CLB Share Price | Core Laboratories, Inc. Stock Analysis & Recommendation

Q: What does Core Laboratories, Inc. do?

Overview:Core Laboratories, Inc. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry and operates within the micro-cap market.Financial Snapshot:Most recent Net Sales: 124 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025) Market-cap: USD 595.53 Million (Micro Cap)Key Metrics:P/E: 21.00 Dividend Yield: 62.71% Debt Equity: 0.45 Return on Equity: 10.05% Price to Book: 2.35Contact Details:Address: Tower a, Level 9, Strawinskylaan 913, AMSTERDAM None: 1077 XX Tel: 31 24 203191 Website: https://www.corelab.com/

Q: Is Core Laboratories, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Core Laboratories, Inc. has changed from mildly bearish to mildly bullish. The weekly and monthly MACD indicators are both mildly bullish, supporting the positive shift in trend. Bollinger Bands are also bullish on both time frames, indicating potential upward momentum. However, the daily moving averages remain mildly bearish, suggesting some short-term caution. The KST shows a bullish weekly signal but is bearish on the monthly, while the Dow Theory and OBV are both mildly bullish across weekly and monthly periods. Overall, the technical stance is mildly bullish, driven primarily by the MACD and Bollinger Bands. Multi-period return data is not available for comparison with the S&P 500.

Q: Is Core Laboratories, Inc. overvalued or undervalued?

As of 21 November 2025, the valuation grade for Core Laboratories, Inc. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is considered overvalued based on its current metrics, with a P/E ratio of 21, a Price to Book Value of 2.08, and an EV to EBITDA ratio of 10.54. In comparison, a peer such as Core Laboratories has a higher P/E ratio of 22.72, while the industry average EV to EBITDA stands at 11.61, suggesting that Core Laboratories, Inc. is trading at a premium relative to its peers.The stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -14.85% compared to the S&P 500's 12.26%, and a one-year return of -30.73% against the index's 11.00%. This trend reinforces the notion that the stock is overvalued in the current market environment.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

732.16 k

Shareholding (Dec 2025)

FII

7.31%

Held by 79 FIIs

DII

35.72%

Held by 65 DIIs

Promoter

0.00%

How big is Core Laboratories, Inc.?

22-Jun-2025

As of Jun 18, Core Laboratories, Inc. has a market capitalization of 595.53 million, with net sales of 517.81 million and a net profit of 28.73 million over the latest four quarters. Shareholder's funds are 251.99 million, and total assets amount to 590.41 million.

View full answer

What does Core Laboratories, Inc. do?

22-Jun-2025

Core Laboratories, Inc. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry. As of March 2025, it has a market cap of $595.53 million, with net sales of $124 million and a P/E ratio of 21.00.

View full answer

Who are in the management team of Core Laboratories, Inc.?

22-Jun-2025

As of March 2022, the management team of Core Laboratories, Inc. includes Lawrence Bruno as Chairman and CEO, with Martha Carnes as Proposed Independent Lead Director, and independent board members Gregory Barnett, Harvey Klingensmith, Michael Straughen, and Monique Van Dijken Eeuwijk.

View full answer

Is Core Laboratories, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Core Laboratories, Inc. shows a mildly bullish trend supported by positive MACD and Bollinger Bands indicators, despite some short-term caution from daily moving averages.

View full answer

Is Core Laboratories, Inc. overvalued or undervalued?

25-Nov-2025

As of November 21, 2025, Core Laboratories, Inc. is considered very expensive and overvalued with a P/E ratio of 21 and underperformed the S&P 500, showing a year-to-date return of -14.85% compared to the index's 12.26%.

View full answer

Compare Core Laboratories, Inc. with Similar Stocks

NextDecade Corp.Talos Energy, Inc.HighPeak Energy, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Positive results in Jun 25

OPERATING CASH FLOW(Y) Highest at USD 54.4 MM
DEBT-EQUITY RATIO (HY) Lowest at 56.4 %

With ROCE of 12.51%, it has a very expensive valuation with a 1.74 Enterprise value to Capital Employed

High Institutional Holdings at 100%

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Oil

Market cap

USD 737 Million (Small Cap)

P/E

28.00

Industry P/E

Dividend Yield

38.11%

Debt Equity

0.35

Return on Equity

9.34%

Price to Book

2.64

Revenue and Profits:

Net Sales:

138 Million

(Quarterly Results - Dec 2025)

Net Profit:

7 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.93%

6 Months

27.84%

1 Year

6.71%

2 Years

0.87%

3 Years

-19.27%

4 Years

-44.1%

5 Years

-50.53%

Core Laboratories, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

1.56%

EBIT Growth (5y)

0.68%

EBIT to Interest (avg)

3.66

Debt to EBITDA (avg)

2.50

Net Debt to Equity (avg)

0.45

Sales to Capital Employed (avg)

1.30

Tax Ratio

32.98%

Dividend Payout Ratio

5.88%

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

12.62%

ROE (avg)

12.43%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.64

EV to EBIT

17.12

EV to EBITDA

13.17

EV to Capital Employed

2.21

EV to Sales

1.59

PEG Ratio

Dividend Yield

38.11%

ROCE (Latest)

12.90%

ROE (Latest)

9.34%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 47 Schemes (56.86%)

Foreign Institutions

Held by 79 Foreign Institutions (7.31%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 2.83% vs 3.30% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -49.66% vs 35.51% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "138.30",
          "val2": "134.50",
          "chgp": "2.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "18.10",
          "val2": "18.90",
          "chgp": "-4.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "2.80",
          "chgp": "-7.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "5.30",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.30",
          "val2": "14.50",
          "chgp": "-49.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "104.40%",
          "val2": "114.00%",
          "chgp": "-0.96%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.52% vs 2.75% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.93% vs -12.97% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "526.50",
          "val2": "523.80",
          "chgp": "0.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "63.50",
          "val2": "63.60",
          "chgp": "-0.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "10.60",
          "val2": "12.40",
          "chgp": "-14.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "6.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "32.50",
          "val2": "32.20",
          "chgp": "0.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "92.80%",
          "val2": "92.80%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

138.30

134.50

2.83%

Operating Profit (PBDIT) excl Other Income

18.10

18.90

-4.23%

Interest

2.60

2.80

-7.14%

Exceptional Items

0.00

5.30

-100.00%

Consolidate Net Profit

7.30

14.50

-49.66%

Operating Profit Margin (Excl OI)

104.40%

114.00%

-0.96%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.83% vs 3.30% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -49.66% vs 35.51% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

526.50

523.80

0.52%

Operating Profit (PBDIT) excl Other Income

63.50

63.60

-0.16%

Interest

10.60

12.40

-14.52%

Exceptional Items

0.00

6.60

-100.00%

Consolidate Net Profit

32.50

32.20

0.93%

Operating Profit Margin (Excl OI)

92.80%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.52% vs 2.75% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 0.93% vs -12.97% in Dec 2024

All Annual Results

Company CV

About Core Laboratories, Inc.

Core Laboratories, Inc.

Oil

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Company Coordinates

Company Details

Tower a, Level 9, Strawinskylaan 913 , AMSTERDAM None : 1077 XX

Tel: 31 24 203191

https://www.corelab.com/

Registrar Details